CRYSTAL FORM OF QUINOLINONE COMPOUND AND USE THEREOF

The present invention relates to a crystal form of a quinolinone compound and a use thereof. The present invention further relates to a pharmaceutical composition comprising the crystal form, and a use of the crystal form or the pharmaceutical composition in the preparation of a drug for the treatme...

Full description

Saved in:
Bibliographic Details
Main Authors ZUO, Yinglin, ZONG, Qiao, WANG, Xiaojun, CHEN, Liang
Format Patent
LanguageChinese
English
French
Published 03.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a crystal form of a quinolinone compound and a use thereof. The present invention further relates to a pharmaceutical composition comprising the crystal form, and a use of the crystal form or the pharmaceutical composition in the preparation of a drug for the treatment and prevention of HIF-related and/or EPO-related diseases (such as anemia). La présente invention concerne une forme cristalline d'un composé de quinolinone et son utilisation. La présente invention concerne en outre une composition pharmaceutique comprenant la forme cristalline, et une utilisation de la forme cristalline ou de la composition pharmaceutique dans la préparation d'un médicament pour le traitement et la prévention de maladies associées au HIF et/ou associées à l'EPO (telles que l'anémie). 本发明涉及喹啉酮类化合物的晶型及其用途。本发明还涉及包含所述晶型的药物组合物,以及所述晶型或所述药物组合物在制备用于治疗和预防HIF相关和/或EPO相关的疾病(例如贫血)的药物中的用途。
Bibliography:Application Number: WO2020CN131683